A novel mutation in TARDBP segregates with amyotrophic lateral sclerosis in a large family with early onset and fast progression. Issue 3 (2nd April 2020)

• Record Type: Journal Article
• Authors: Goldstein, Orly; Kedmi, Merav; Gana-Weisz, Mali; Nefussy, Beatrice; Vainer, Batel; Fainmesser, Yaara; Drory, Vivian E.; Orr-Urtreger, Avi
• Is Part Of: Amyotrophic lateral sclerosis and frontotemporal degeneration. Volume 21:Issue 3/4(2020)
• Page Start: 280
• Page End: 285
• Publication Date: 2020-04-02
• Subjects: Whole-exome-sequencing -- TARDBP -- familial ALS; 616.839
• DOI: 10.1080/21678421.2020.1747496
• Languages: English
• ISSNs: 2167-8421

Abstract

Abstract: Objective: To identify the genetic background of ALS segregating in a large Bedouin family in Israel. Methods: Exome sequencing was carried out on three siblings in a family segregating ALS, two affected and one without neurological symptoms. Filtering for causative variants and for modifiers was carried out. Eight variants were confirmed by Sanger sequencing and genotyped on nine available members of the family (three affected and six unaffected). Results: We report the identification of a novel mutation in TARDBP, p.Ala321Asp, segregating in the family. The patients are affected with early onset (average age 34.5, 21–43 years old) and fast progressive disease. The mutation is in exon 6, in the glycin-rich domain, and is predicted to be deleterious. Additional rare, potentially deleterious variants were observed in the three patients, only one of them, PLEKHG5- Phe538Leu, which is located 4.5 Mb upstream to the TARDBP, was also fully segregating in the family. Conclusion: We identified a novel mutation in TARDBP which segregates with the disease in a large family. Additional rare variants were identified, and the combination of next-generation-sequencing together with linkage analysis was optimal to identify causality and modification, emphasizing the importance of combining the two analyses. Burden of deleterious variants may be associated with early age at onset.